Piretanide
Indications
Registered South African indications:
- Oedema
- Hypertension
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Hypersensitivity to sulphonamide derivatives
- Pregnancy
- Breastfeeding
- Renal failure with anuria
- Hepatic failure associated with clouding of consciousness
- Serious potassium deficiency
- Serious sodium deficiency and/or diminished blood volume with or without concurrent lowering of blood pressure
- Should not be used in children
Cautions
- Metabolic alkalosis
- Diabetes mellitus
- Gout
- Prostatic hypertrophy
- Abnormalities of bladder emptying
Adult dosage
Forms avail. in SA and covered in this monograph: tab
Oedema
- Oral (tab): Initial: 6mg, dly; Maintenance: 3-6mg, dly
Hypertension - mild to moderate
- Oral (tab): Initial: 6mg, dly; Titrate at intervals of 2-4 weeks; Max: 12mg/24hrs
Advise diet rich in potassium and restrict salt intake
Paediatric dosage
Not established for use in children (see Contraindications)
Special populations
Pregnancy
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Adverse reactions
Central Nervous System Disorders
- Headache
- Dizziness
Cardiovascular Disorders
- Hypovolaemia
- Hypotension
- Vasculitis
Gastrointestinal Disorders
- Nausea and vomiting
- Digestive disorders
- Diarrhoea
- Dry mouth
Genitourinary Disorders
- Dehydration
- Impotence
- Urinary outflow obstruction
- Increased serum urea
- Increased serum creatinine
Endocrine and Metabolic Disorders
- Hypokalaemia
- Hyponatraemia
- Metabolic alkalosis
- Hypocalcaemia
- Hypomagnesemia
- Impaired glucose tolerance
- Latent diabetes mellitus
Musculoskeletal Disorders
- Gout
Skin and Subcutaneous Tissue Disorders
- Photosensitivity
- Allergic reactions
Immune, Blood and Lymphatic System Disorders
- Thrombophilia
- Thrombocytopaenia
Sensory Disorders
- Visual disturbances
Interactions
- Nephrotoxic agents
- Digoxin
- Corticosteroids
- Laxatives
- Carbenoxolone
- Liquorice
- Antihypertensive agents
- Antidiabetic agents
- Salicylates
- Muscle relaxants
- Pressor amines
- Lithium
- Probenecid
- Non-steroidal anti-inflammatory drugs
Monitoring
None routine. Specific cases may require
- Renal function
- Electrolytes
Mechanism of action
Piretanide inhibits the reabsorption of sodium, mainly from the Loop of Henle but also from the proximal convoluted tubule. Active chloride transport is inhibited in the Loop of Henle.
Dosage forms
- Tablet
Formulation
Tablet 6mg
- Arelix (Sanofi) originator
References
1. SAMF_Page 149 2. https://drive.google.com/drive/folders/0B0xnChtF7vdua2JEeC1IeU9zb0U (23/03/1994_Sanofi_Arelix_6mg_tab) **No SPC
Brands & products
2 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days oldtabletGeneric· 2 products
from R5.40/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Arelix 3 Mg Tablets | 3 mg | 30 | S3 | R161.96 | R5.40 | R67.92 | 807796018 |
| Arelix 6 Mg Tablets | 6 mg | 30 | S3 | R397.73 | R13.26 | R134.63 | 807818003 |
- Arelix
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.